Gastrointestinal Hormones

Gastrointestinal Hormones: The Gut’s Hidden Hormone System

When people think about hormones, they usually picture the thyroid, the adrenal glands, or the reproductive system covered elsewhere in this series. Few people realize that the digestive tract itself is one of the body’s largest and busiest hormone-producing organs, quietly coordinating everything from stomach acid production to the sensation of fullness after a meal.

Key Takeaways

  • The gastrointestinal tract is the body’s largest endocrine organ by cell count, producing a wide variety of distinct hormones that coordinate digestion.
  • Secretin, discovered in 1902, was the first hormone ever scientifically identified, and its discovery directly led to the word “hormone” itself being coined in 1905.
  • Major gastrointestinal hormones include gastrin, secretin, CCK, ghrelin, GLP-1, GIP, peptide YY, motilin, somatostatin, VIP, and oxyntomodulin, each with a distinct role in digestion, appetite, or blood sugar regulation.
  • These hormones work together in a coordinated sequence throughout the digestive process, from stomach acid production to the sense of post-meal fullness.
  • The incretin effect, driven by GLP-1 and GIP, is the direct biological basis for major diabetes and weight-loss drugs like semaglutide and tirzepatide.
  • Rare tumors affecting these hormone-producing cells, like gastrinomas and VIPomas, can cause severe, distinctive medical conditions.

Gut Hormones

Gastrointestinal hormones are chemical messengers produced by specialized cells scattered throughout the stomach and intestinal lining. They control digestion, appetite, and blood sugar regulation by coordinating with the pancreas, gallbladder, and brain. This hormone system was actually the first one ever scientifically discovered, back in 1902, and it remains central to modern medicine today, forming the biological basis for major diabetes and weight-loss drugs.

The Gut: The Body’s Largest, Most Overlooked Endocrine Organ

It’s easy to think of the digestive system as purely mechanical, a tube that breaks down food and absorbs nutrients. In reality, the lining of your stomach and intestines contains millions of specialized hormone-producing cells, collectively called enteroendocrine cells, scattered throughout the gut wall. Taken together, these cells make the gastrointestinal tract the largest endocrine organ in the human body by total cell count, producing a wider variety of distinct hormones than any single gland covered elsewhere in this series, including the pituitary gland.

This matters because so much of modern medicine’s most significant recent progress, particularly around diabetes and weight management, has come directly from better understanding this exact hormone system.

The Discovery That Started It All: Secretin and the Birth of the Word “Hormone”

This is a genuinely remarkable piece of medical history worth knowing. In 1902, English physiologists William Bayliss and Ernest Starling were investigating what triggers the pancreas to release digestive juices when food enters the small intestine. The prevailing assumption at the time was that this had to be controlled directly by nerve signals, since that was the only known method of fast bodily communication.

To test this, they surgically cut the nerve connections to a section of intestine in an experimental animal and then introduced acidic material into it, expecting no pancreatic response. To their surprise, the pancreas responded anyway, pouring out digestive juices despite having no working nerve connection to the intestine. This meant something else, something chemical, was carrying the signal through the bloodstream instead.

They identified this chemical messenger and named it secretin. Three years later, in 1905, Starling coined an entirely new word to describe this class of chemical messenger: hormone, derived from the Greek word “hormon,” meaning “to excite” or “to set in motion.” In other words, the entire field of endocrinology, the study of hormones, effectively began with the discovery of a gastrointestinal hormone. Secretin remains historically significant as the very first hormone ever scientifically identified.

How Gastrointestinal Hormones Actually Work

Enteroendocrine cells are scattered throughout the lining of the stomach and intestines, and different types of these cells are concentrated in different sections of the digestive tract. Each cell type responds to specific triggers, the presence of acid, fat, protein, or sugar in the gut, or physical stretching of the intestinal wall, and releases its corresponding hormone in response.

Once released, these hormones can act in a few different ways:

  • Endocrine signaling, where the hormone travels through the bloodstream to reach distant organs, like the pancreas or brain
  • Paracrine signaling, where the hormone acts locally, affecting nearby cells without needing to enter general circulation
  • Neurocrine signaling, where the hormone influences nearby nerve endings, particularly branches of the vagus nerve, which then relay the signal to the brain

This layered communication system is part of why gastrointestinal hormones can coordinate such a wide range of effects, some acting almost instantly on nearby tissue, others taking a more indirect route through the bloodstream to influence organs and brain regions much further away.

The Major Gastrointestinal Hormones

Gastrin

Gastrin is produced by G cells located in the stomach’s antrum, the lower portion of the stomach closest to the small intestine. It’s released in response to the presence of food, particularly protein, along with stomach stretching and certain nerve signals. Once released, gastrin’s main job is stimulating the stomach’s parietal cells to produce hydrochloric acid, which is essential for breaking down food and killing ingested bacteria. Excess gastrin production, seen in a rare condition called Zollinger-Ellison syndrome, can cause severe, treatment-resistant ulcers due to extreme overproduction of stomach acid.

Secretin

As covered above, secretin holds the distinction of being the first hormone ever identified. It’s produced by S cells in the duodenum, the first section of the small intestine, and is released specifically in response to acidic stomach contents entering the intestine. Its primary job is triggering the pancreas to release a bicarbonate-rich fluid, which neutralizes that incoming stomach acid, protecting the delicate intestinal lining. Secretin also tends to inhibit stomach motility and gastrin release, helping the digestive system transition smoothly from the stomach phase of digestion to the intestinal phase.

Cholecystokinin (CCK)

Cholecystokinin, almost always shortened to CCK, is produced by I cells in the duodenum and jejunum, released specifically in response to fat and protein in the gut. CCK has two major jobs: triggering the gallbladder to contract and release bile, which helps digest fats, and signaling the pancreas to release digestive enzymes. CCK also plays a genuine role in satiety, contributing to the feeling of fullness after a fat- or protein-rich meal, working alongside several of the hormones covered below.

Ghrelin

Ghrelin, covered in extensive detail in our dedicated ghrelin guide, deserves a brief mention here since it’s one of the relatively few gastrointestinal hormones that increases appetite rather than suppressing it. Produced mainly by cells in the stomach, ghrelin rises before meals and signals hunger directly to the brain’s hypothalamus, making it something of an outlier among the mostly appetite-suppressing hormones covered in this article.

GLP-1 (Glucagon-Like Peptide-1)

GLP-1 is produced by L cells, concentrated mainly in the ileum and colon, and released in response to nutrients, particularly carbohydrates and fats, reaching the lower intestine. Glucagon-like peptide-1 has become one of the most clinically significant gastrointestinal hormones in modern medicine, and for good reason: it stimulates insulin release from the pancreas in a glucose-dependent way, suppresses glucagon release, slows gastric emptying, and promotes satiety by acting on the brain.

This exact hormone is the biological basis for semaglutide (Ozempic, Wegovy), covered extensively in our earlier guides on FDA-approved peptides and semaglutide’s kidney disease research. Semaglutide is essentially an engineered, longer-lasting version of this natural gut hormone.

GIP (Glucose-Dependent Insulinotropic Polypeptide)

GIP is produced by K cells, concentrated mainly in the duodenum, and released in response to fat and glucose in the gut. Like GLP-1, it stimulates insulin release from the pancreas, though through a somewhat different signaling pathway. GIP and GLP-1 are collectively known as incretin hormones, a term explained in more detail below.

GIP is the second target of tirzepatide (Mounjaro, Zepbound), covered in our tirzepatide FAQ, which activates both the GIP and GLP-1 receptors simultaneously, part of why it has shown larger average weight-loss results than GLP-1-only medications in clinical trials.

Peptide YY (PYY)

Peptide YY is released by the same L cells that produce GLP-1, meaning the two hormones are often released together in response to a meal. PYY contributes significantly to satiety and is part of what researchers call the “ileal brake,” a mechanism where nutrients reaching the lower small intestine slow down the rate of stomach emptying and appetite, essentially telling the upper digestive system to ease off since food is already further along in the process.

Motilin

Motilin comes from M cells in the small intestine. It works differently from most other hormones on this list because it becomes active mainly between meals rather than in response to eating.

Motilin helps coordinate a recurring pattern of intestinal muscle contractions called the migrating motor complex (MMC). This pattern moves through the digestive tract roughly every 90 to 120 minutes during fasting.

The MMC acts like a housekeeping system for the gut. It helps clear leftover food particles, secretions, and bacteria from the digestive tract between meals.

Somatostatin

Somatostatin comes from D cells found throughout the stomach, intestines, and pancreas.

It plays a very different role from most of the hormones covered here. Somatostatin mainly acts as an inhibitory hormone. It suppresses the release of several other gastrointestinal hormones, including gastrin, CCK, and secretin.

It also slows gastric emptying and reduces blood flow to the intestines.

This hormone connects directly to an earlier topic in this series. Octreotide, one of the FDA-approved peptide drugs covered in our peptide overview, is a synthetic analog of somatostatin. Doctors use octreotide to treat certain conditions involving hormone-secreting tumors.

Vasoactive Intestinal Peptide (VIP)

VIP comes from nerve cells within the digestive tract rather than from classic enteroendocrine cells. It still belongs to the same broader hormone family.

Vasoactive Intestinal Peptide relaxes smooth muscle throughout the gut. It also increases blood flow to the intestines and stimulates the intestines to release fluid and electrolytes.

An extremely rare tumor called a VIPoma can produce too much VIP. This excess VIP can cause severe, chronic watery diarrhea because it drives excessive fluid secretion into the intestines.

Oxyntomodulin

Oxyntomodulin comes from the same L cells that produce GLP-1 and PYY. It acts on two receptors at the same time: the GLP-1 receptor and the glucagon receptor.

This dual action has attracted significant scientific interest. Researchers are studying whether oxyntomodulin’s activity can help guide the design of newer weight-loss drugs.

Some experimental drugs combine GLP-1 and glucagon receptor activity in a single molecule. This approach may help suppress appetite while also increasing energy expenditure.

Quick Reference Table: Major Gastrointestinal Hormones

Hormone Produced By Released In Response To Main Effect
Gastrin G cells (stomach antrum) Food, especially protein Stimulates stomach acid production
Secretin S cells (duodenum) Acidic gut contents Triggers pancreatic bicarbonate release
CCK I cells (duodenum, jejunum) Fat and protein Gallbladder contraction, pancreatic enzyme release, satiety
Ghrelin Stomach cells Empty stomach Stimulates hunger
GLP-1 L cells (ileum, colon) Carbohydrates, fats Stimulates insulin, slows gastric emptying, satiety
GIP K cells (duodenum) Fat, glucose Stimulates insulin release
Peptide YY L cells (ileum, colon) Nutrients in lower gut Satiety, slows gastric emptying
Motilin M cells (small intestine) Fasting state Triggers interdigestive gut-cleaning contractions
Somatostatin D cells (stomach, intestines, pancreas) Multiple triggers Broadly inhibits other GI hormones
VIP Enteric nerve cells Neural signaling Relaxes gut muscle, stimulates secretion
Oxyntomodulin L cells (ileum, colon) Nutrients in lower gut Dual GLP-1/glucagon receptor activity

Following a Meal: How These Hormones Coordinate Digestion Step by Step

Understanding each hormone individually is useful, but seeing how they work together across an actual meal makes the whole system click into place.

Before eating, ghrelin rises and motilin drives the interdigestive housekeeping contractions that clear the gut between meals.

As food enters the stomach, gastrin is released, ramping up acid production to begin breaking down what you’ve eaten, while ghrelin levels begin to drop.

As partially digested food moves into the small intestine, secretin is released in response to the acidic content, triggering the pancreas to release neutralizing bicarbonate. At the same time, CCK responds to fat and protein content, triggering gallbladder contraction and pancreatic enzyme release to continue digestion.

As nutrients are absorbed further along the intestine, GLP-1, GIP, and PYY are released, working together to stimulate insulin release, slow down how quickly the stomach empties, and generate the feeling of fullness.

Throughout this entire process, somatostatin works quietly in the background, helping to keep the whole system from overshooting by suppressing the other hormones once their job is sufficiently done.

This coordinated sequence is a genuinely elegant example of the body regulating itself without any conscious input, all discovered because Bayliss and Starling wanted to understand one small piece of it more than a century ago.

The Incretin Effect: Why GI Hormones Are Central to Modern Diabetes and Weight-Loss Drugs

This deserves its own section because it connects directly to some of the most important medicines in use today.

Researchers noticed this effect decades ago. They found that people release much more insulin when they drink glucose than when doctors inject the same amount of glucose directly into the bloodstream through an IV.

Scientists call this difference the incretin effect. GLP-1 and GIP drive this effect. The gut releases these hormones when food enters the digestive system. They then send an extra signal that tells the pancreas to release more insulin, beyond the signal created by rising blood sugar alone.

People with type 2 diabetes often have a weaker incretin effect. Their gut hormones do not produce as strong an insulin-boosting signal as they normally should.

This finding helped inspire the development of GLP-1 receptor agonists. Later, researchers developed dual GLP-1/GIP drugs such as tirzepatide.

These medicines essentially mimic or strengthen hormone signals that the gut already produces naturally. They can extend these signals and make them stronger, helping restore or amplify the incretin effect.

This story provides one of the clearest examples of basic hormone research leading directly to major medical treatments. It traces a path from Bayliss and Starling’s 1902 discovery of secretin to some of the world’s most widely used medicines today.

When Gastrointestinal Hormones Go Wrong

Several rare but medically important conditions involve gastrointestinal hormones being produced in abnormal amounts, usually due to a tumor arising from the hormone-producing cells themselves.

Condition Hormone Involved What Happens
Zollinger-Ellison syndrome Gastrin (gastrinoma) Severe acid overproduction, treatment-resistant ulcers
VIPoma VIP Severe chronic watery diarrhea and electrolyte loss
Carcinoid syndrome Serotonin and related gut hormones Flushing, diarrhea, and other symptoms from hormone-secreting tumors
Insulinoma Insulin (pancreatic, closely related system) Dangerously low blood sugar episodes
Glucagonoma Glucagon High blood sugar, distinctive skin rash, weight loss

Beyond these rare tumor-related conditions, more common disruptions to this hormone system include impaired incretin function in type 2 diabetes, and altered gut hormone patterns seen after bariatric surgery, which, similar to the pattern discussed in our FDA-approved peptides guide regarding ghrelin, appears to shift several of these hormones (including GLP-1 and PYY) toward greater satiety and reduced hunger, contributing to the significant weight loss many patients experience after these procedures.

FDA-Approved Medications Built on Gastrointestinal Hormones

Medication Hormone System Targeted Approved Use
Semaglutide (Ozempic, Wegovy) GLP-1 receptor agonist Type 2 diabetes, chronic weight management
Tirzepatide (Mounjaro, Zepbound) GLP-1 and GIP receptor agonist Type 2 diabetes, chronic weight management
Liraglutide (Victoza, Saxenda) GLP-1 receptor agonist Type 2 diabetes, weight management
Octreotide (Sandostatin) Somatostatin analog Acromegaly, hormone-secreting tumors
Secretin (ChiRhostim) Synthetic secretin Diagnostic testing of pancreatic function
Sincalide (Kinevac) Synthetic CCK analog Diagnostic testing of gallbladder function

It’s worth noting that even secretin, the very hormone that started this entire field of study in 1902, is still in clinical use today, now manufactured as a synthetic diagnostic tool used to evaluate pancreatic function, a fitting full-circle detail in the history of this hormone system.

Frequently Asked Questions

Which gastrointestinal hormone was discovered first?

Secretin, discovered by Bayliss and Starling in 1902. It was actually the first hormone of any kind ever scientifically identified, leading directly to the creation of the word “hormone” itself in 1905.

Why do GLP-1 drugs cause nausea?

As covered in our guide on the causes of nausea, GLP-1 receptor agonists act directly on brainstem nausea pathways while also slowing gastric emptying, both of which contribute to this common side effect.

Is ghrelin considered a typical gastrointestinal hormone?

It comes from the gastrointestinal tract, like the other hormones discussed here. However, it stands out because it increases appetite. Most other GI hormones help regulate digestion or reduce appetite.

What’s the difference between GLP-1 and GIP?

Both are incretin hormones that stimulate insulin release in response to food, but different intestinal cells produce them in different parts of the intestine, and each hormone acts through its own receptor. Tirzepatide stands out because it targets both pathways at the same time.

Do gastrointestinal hormones affect anything besides digestion?

Yes, significantly. Several, including GLP-1, GIP, and PYY, directly influence appetite and blood sugar regulation. That’s why researchers have made them central to diabetes and weight-management medicine rather than limiting them to their roles in digestion.


Discover more from Peptide News Forum

Subscribe to get the latest posts sent to your email.

2 responses to “Gastrointestinal Hormones”

  1. […] is a synthetic peptide. It copies two natural gut hormones: GIP and GLP-1. Your gut releases both after you eat. Lilly built it as a single peptide designed […]

  2. […] Tirzepatide is a dual GIP and GLP-1 receptor agonist. Which means it works by mimicking two gut hormones. […]

Leave a Reply